MustGrow Biologics - CEO, Corey Giasson.
CEO, Corey Giasson.
Source: CSE TV.
  • MustGrow (MGRO) has partnered with Bayer to develop sustainable organic biologicals
  • MustGrow technologies under consideration pertain to preplant soil fumigation, bioherbicide applications and postharvest food preservation of potatoes
  • Bayer will acquire exclusive rights to certain technologies if proven commercially viable
  • MustGrow is an agricultural biotech company providing natural science-based biological solutions for high-value crops
  • MustGrow (MGRO) is up by 12.39 per cent trading at $3.99 per share

MustGrow (MGRO) has partnered with Bayer to develop sustainable organic biologicals.

Under the exclusive agreement, Bayer will evaluate the efficacy and commercial potential of MustGrow’s biological technologies in key agricultural regions. 

MustGrow technologies under consideration pertain to pre-plant soil fumigation, bioherbicide applications and postharvest food preservation of potatoes, including sprout inhibition, in Europe, Asia Pacific, Africa and the Middle East.

MustGrow’s biopesticides harness the mustard seed’s natural defence mechanism to treat diseases, pests and weeds.

“We are thrilled to accelerate the development and understanding of our technology with Bayer in these important food producing regions,” stated Corey Giasson, CEO of MustGrow. “I am hopeful that we potentially have a sustainable solution for farmers to help with key issues in their production of food.”

MustGrow is an agricultural biotech company providing natural science-based biological solutions for high-value crops.

MustGrow (MGRO) is up by 12.39 per cent trading at $3.99 per share as of 9:36 am EST.

More From The Market Online
Bombardier - Bombardier's Challenger 3500 business jet.

Bombardier reveals NetJets as buyer behind US$6 billion order

Bombardier (TSX:BBD.A) names NetJets as the previously announced anonymous buyer of 12 Challenger 3500 aircraft in December 2023.

What is behind the latest cannabis stock jump?

In a groundbreaking move, the U.S. federal administration is set to reclassify cannabis as a lower-risk substance.

Amazon stock reaches for record highs after earnings report

Amazon (NDAQ:AMZN) impressed investors with its Q1 2024 performance, as the tech giant beat Wall Street estimates.